ClassID:

170823

G01N2800/164 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Ophthalmology Retinal disorders, e.g. retinopathy

Recent Application in this class:
#1
20250347701
2025-11-13

METHODS FOR MONITORING MOLECULAR BIOMARKERS FOR AGING AND DISEASE

#2
20250305024
2025-10-02

RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES

#3
20250283896
2025-09-11

PROBES AND METHODS FOR TARGETED VISUALIZATION OF NLRP3 INFLAMMASOMES

#4
20250231200
2025-07-17

Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases

#5
20250093370
2025-03-20

BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES

#6
20240418734
2024-12-19

BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE

#7
20240175022
2024-05-30

RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition

#8
20230417767
2023-12-28

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION

#9
20230408489
2023-12-21

ASSAYS FOR POTENCY OF HUMAN RETINAL PIGMENT EPITHELIUM (RPE) CELLS AND PHOTORECEPTOR PROGENITORS

#10
20230355621
2023-11-09

FFA1 (GPR40) AS A THERAPEUTIC TARGET FOR NEURAL ANGIOGENESIS DISEASES OR DISORDERS

#11
20230260126
2023-08-17

PROCESSING FUNDUS IMAGES USING MACHINE LEARNING MODELS

#12
20230194550
2023-06-22

STIMULATION OF THE HEALING PROCESS ON THE RETINAL PIGMENT EPITHELIUM AFTER R:GEN WITH RTF TECHNOLOGY

#13
20230078745
2023-03-16

Blood biomarkers and diagnostic methods for small vessel diseases

#14
20230051804
2023-02-16

Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors

#15
20230034053
2023-02-02

METABOLIC RESCUE OF RETINAL DEGENERATION

#16
20220401580
2022-12-22

OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION

#17
20220397569
2022-12-15

ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION

#18
20220373567
2022-11-24

PREDICTION OF THE CONTENT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE RETINA BY MEASURING 7 CHOLESTEROL ESTER MOLECULES

#19
20220155295
2022-05-19

Predictive Markers Useful in the Treatment of Wet Age-Related Macular Degeneration

#20
20220146533
2022-05-12

Biomarkers useful in the treatment of subjects having diseases of the eye

#21
20220146531
2022-05-12

A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF DIABETIC RETINOPATHY AND USE THEREOF

#22
20220146530
2022-05-12

A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF AGE-RELATED MACULAR DEGENERATION AND USE THEREOF

#23
20220146519
2022-05-12

INTEGRIN ALPHA V BETA 3 TARGETING PROBE FOR DIAGNOSING RETINOCHOROIDAL NEOVASCULAR DISEASES AND PREPARATION METHOD THEREFOR

#24
20220128573
2022-04-28

BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF

#25
20210348210
2021-11-11

RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES

#26
20210322414
2021-10-21

FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders

#27
20210317403
2021-10-14

STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME

#28
20210239715
2021-08-05

ASSAY FOR THE DIAGNOSIS OF MACULAR DEGENERATION

#29
20210209762
2021-07-08

Processing fundus images using machine learning models

#30
20210180129
2021-06-17

METHODS OF PREDICTING THE DEVELOPMENT OF AMD BASED ON CHROMOSOME 1 AND CHROMOSOME10

#31
20210032709
2021-02-04

Mutations in rhodopsin gene in zebrafish and uses thereof

#32
20200384126
2020-12-10

Detection of high risk drusen

#33
20200377888
2020-12-03

RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition

#34
20200217852
2020-07-09

Quantitation of Free and Total N-Acetylcysteine Amide and Its Metabolite N-Acetylcysteine in Human Plasma Using Derivatization and Electrospray LC-MS/MS

#35
20200208159
2020-07-02

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

#36
20200172974
2020-06-04

BIOMARKER FOR ANTI-TNF THERAPY IN RETINAL DISEASES

#37
20200116734
2020-04-16

Biosensor and application of the same

#38
20200103419
2020-04-02

BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES

#39
20190285653
2019-09-19

Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization

#40
20190180441
2019-06-13

Processing fundus images using machine learning models

#41
20190127690
2019-05-02

Method for producing retinal tissue

#42
20190072550
2019-03-07

Predictive markers useful in the treatment of wet age-related macular degeneration

#43
20190049465
2019-02-14

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION

#44
20180346998
2018-12-06

Mutations in rhodopsin gene in zebrafish and uses thereof

#45
20180335436
2018-11-22

Diagnostics and Therapeutics for Macular Degeneration-Related Disorders

#46
20180194854
2018-07-12

Endoglin Antibodies

#47
20180127823
2018-05-10

Method for determination and identification of cell signatures and cell markers

#48
20180113140
2018-04-26

ASSAY FOR THE DIAGNOSIS OF MACULAR DEGENERATION

#49
20180057602
2018-03-01

COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS

#50
20180052150
2018-02-22

Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors

#51
20180045738
2018-02-15

Methods of use for intermediate filament protein probes

#52
20180036974
2018-02-08

Smart contact lenses and smart glasses

#53
20180030455
2018-02-01

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

#54
20170370945
2017-12-28

Biomarkers useful in the treatment of subjects having diseases of the eye

#55
20170328896
2017-11-16

ASSAY SYSTEMS FOR POINT OF CARE DETECTION OF OCULAR ANALYTES

#56
20170315135
2017-11-02

BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING RETINITS PIGMENTOSA

#57
20170176416
2017-06-22

Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions

#58
20170080060
2017-03-23

Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide

#59
20170044267
2017-02-16

Endoglin antibodies

#60
20160220702
2016-08-04

Compositions and methods for treatment of diabetic retinopathy

#61
20160178641
2016-06-23

BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION

#62
20160084853
2016-03-24

Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis

#63
20160018415
2016-01-21

Marker for diagnosing diabetic retinopathy and use thereof

#64
20160009811
2016-01-14

Endoglin antibodies

#65
20160002641
2016-01-07

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

#66
20150377908
2015-12-31

Methods of diagnosing, treating and monitoring diabetic retinopathy

#67
20150329591
2015-11-19

Azapeptides as CD36 binding compounds

#68
20150276718
2015-10-01

Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity

#69
20140187498
2014-07-03

Predicting and treating diabetic complications

#70
20130203686
2013-08-08

Azapeptides as CD36 binding compounds

#71
20120309835
2012-12-06

METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES

#72
20120294864
2012-11-22

Endoglin antibodies

#73
20120282230
2012-11-08

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GENETIC AND RETINAL DISEASE

#74
20120277286
2012-11-01

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES

#75
20120238632
2012-09-20

MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION

#76
20120219970
2012-08-30

METHODS FOR MODULATING MACROPHAGE PROLIFERATION IN OCULAR DISEASE USING POLYAMINE ANALOGS

#77
20120202885
2012-08-09

METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES

#78
20120196286
2012-08-02

METHOD AND APPARATUS FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION

#79
20120196281
2012-08-02

FUNCTIONALIZED ORGANOTYPIC SYSTEMS

#80
20120183523
2012-07-19

Methods and Compounds for Promoting Vessel Regression

#81
20120135430
2012-05-31

Complement assays and uses thereof

#82
20120071356
2012-03-22

Variants in complement regulatory genes predict age-related macular degeneration

#83
20120064010
2012-03-15

Method of using CCR3 binding agents to detect choroidal neovascularization

#84
20120046189
2012-02-23

MARKERS RELATED TO AGE-RELATED MACULAR DEGENERATION AND USES THEREFOR

#85
20120015884
2012-01-19

Polypeptides for Specific Targeting to Otx2 Target Cells

#86
20110305641
2011-12-15

Compositions and methods for treatment of angiogenesis-associated ocular disorders

#87
20110294891
2011-12-01

METHODS AND COMPOSITIONS FOR TREATING OPTHALMIC CONDITIONS WITH RETINOL DERIVATIVES

#88
20110269248
2011-11-03

BIO-MARKERS FOR DIAGNOSING DIABETIC RETINOPATHY

#89
20110268723
2011-11-03

CCR3 inhibition for ocular angiogenesis and macular degeneration

#90
20110263483
2011-10-27

Compositions and methods for inhibiting vascular permeability

#91
20110244504
2011-10-06

Biomarkers of inflammation in Bruch's membrane of the human retina

#92
20110183340
2011-07-28

Phenotype-Genotype Relationship in Age-Related Macular Degeneration

#93
20110182908
2011-07-28

Diagnostics and Therapeutics for Macular Degeneration-Related Disorders

#94
20110182819
2011-07-28

Methods and Compounds for Promoting Vessel Regression

#95
20110159016
2011-06-30

HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSIS AND/OR TREATMENT OF RETINAL DISORDERS

#96
20110142850
2011-06-16

Method of treating CD40-mediated diseases

#97
20110117557
2011-05-19

Methods and Compositions For Diagnosis of Age-Related Macular Degeneration

#98
20110076263
2011-03-31

Endoglin antibodies

#99
20110044979
2011-02-24

DOMAIN ANTIBODY CONSTRUCT

#100
20110027185
2011-02-03

Methods of Screening for Anti-Angiogenic Compounds

#101
20110015136
2011-01-20

Humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration

#102
20100304369
2010-12-02

Method and apparatus for diagnosing age-related macular degeneration

#103
20100298443
2010-11-25

Methods and compositions for treating ophthalmic conditions with retinyl derivatives

#104
20100248263
2010-09-30

BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION

#105
20100240138
2010-09-23

DIAGNOSIS OF AGE-RELATED MACULAR DEGENERATION USING BIOMARKERS

#106
20100210566
2010-08-19

Azapeptides as CD36 binding compounds

#107
20100168051
2010-07-01

Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress

#108
20100146646
2010-06-10

METHOD OF MONITORING RETINOPATHY

#109
20100069301
2010-03-18

Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability

#110
20100047914
2010-02-25

Agent detection and/or quantitation in a biological fluid

#111
20100009393
2010-01-14

Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration

#112
20100004168
2010-01-07

Use of Crystallin For The Modulation of Angiogenesis

#113
20090312394
2009-12-17

Protection against and treatment of age related macular degeneration

#114
20090285840
2009-11-19

METHODS FOR TREATING PATHOLOGICAL NEOVASCULARIZATION

#115
20090263801
2009-10-22

Phenotype-Genotype Relationship in Age-Related Macular Degeneration

#116
20090215765
2009-08-27

Methods of identifying neuroprotective compounds for retinal ganglion cells

#117
20090208511
2009-08-20

Method for identifying diabetic patients at increased risk for pathological complications

#118
20090186032
2009-07-23

Bio-Markers For Diagnosing Diabetic Retinopathy

#119
20090155176
2009-06-18

Compositions and methods for treatment of diabetic retinopathy

#120
20090123375
2009-05-14

CCR3 inhibition for ocular angiogenesis and macular degeneration

#121
20090069231
2009-03-12

COMPOSITIONS AND METHODS FOR TREATING DIABETIC EYE DISEASE

#122
20090061465
2009-03-05

COMPOSITION FOR ANALYZING DIABETES MELLITUS AND/OR RETINAL VASCULAR DISEASE AND ANALYZING METHOD THEREOF

#123
20090054532
2009-02-26

Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation

#124
20090053816
2009-02-26

HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSIS AND/OR TREATMENT OF RETINAL DISORDERS

#125
20090048196
2009-02-19

Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions

#126
20080318835
2008-12-25

Novel Integrin Ligand ITGL-TSP

#127
20080318264
2008-12-25

Biomarkers Associated With Age-Related Macular Degeneration

#128
20080294349
2008-11-27

Quantitative Evaluation and Image Analysis of Choroidal Neovascular Membrane and Other Retinal and Subretinal Lesions

#129
20080293626
2008-11-27

Pigment epithelium-derived factor as a therapeutic agent for vascular leakage

#130
20080274453
2008-11-06

Diagnostics and therapeutics for macular degeneration

#131
20080261211
2008-10-23

Variants in complement regulatory genes predict age-related macular degeneration

#132
20080193435
2008-08-14

Revascularization of Ischemic Retinal Tissue and Screening Method Therefor

#133
20080131418
2008-06-05

Diagnostics and therapeutics for macular degeneration-related disorders

#134
20080118928
2008-05-22

DIAGNOSTICS AND THERAPEUTICS FOR ARTERIAL WALL DISRUPTIVE DISORDERS

#135
20070274921
2007-11-29

Diagnostics and therapeutics for ocular disorders

#136
20070224644
2007-09-27

Ocular fluid markers

#137
20070202105
2007-08-30

Domain antibody construct

#138
20070141570
2007-06-21

Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods

#139
20070101445
2007-05-03

Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases

#140
20070027084
2007-02-01

Novel Integrin Ligand ITGL-TSP

#141
20070026495
2007-02-01

Novel Integrin Ligand ITGL-TSP

#142
20060286604
2006-12-21

Lectin binding to choroidal neovascularization

#143
20060269963
2006-11-30

Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it

#144
20060263819
2006-11-23

Diagnostics and therapeutics for macular degeneration-related disorders

#145
20060240484
2006-10-26

Protein for diagnosing diabetic retinopathy

#146
20060211057
2006-09-21

Methods and compounds for promoting vessel regression

#147
20060167088
2006-07-27

Methods and compositions for treating ophthalmic conditions with retinyl derivatives

#148
20060135460
2006-06-22

Methods, assays and compositions for treating retinol-related diseases

#149
20060099714
2006-05-11

Detection and analysis of ophthalmically-relevant fluorescent molecules

#150
20060094063
2006-05-04

Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation

#151
20060067935
2006-03-30

Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration

#152
20050287601
2005-12-29

Diagnostics and therapeutics for macular degeneration-related disorders

#153
20050256207
2005-11-17

Methods for modulating macrophage proliferation in ocular disease using polyamine analogs

#154
20050208618
2005-09-22

Novel integrin ligand ITGL-TSP

#155
20050119536
2005-06-02

Diagnostics and therapeutics for arterial wall disruptive disorders